Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
28/06/2023 22:16
June 28 (Reuters) - Finch Therapeutics Group Inc
FNCH.O :
* FINCH THERAPEUTICS GROUP INC- ON JUNE 27, GOT LETTER FROM
NASDAQ
THAT CO HAS REGAINED COMPLIANCE WITH NASDAQ’S LISTING RULE
5450(A)(1)
Further company coverage: FNCH.O
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp